Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB‐IIIC vs stage IV epithelial ovarian cancer after primary surgery-Reference-Cited by-同舟云学术

Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB‐IIIC vs stage IV epithelial ovarian cancer after primary surgery

Published:2018-10-26 Issue:1 Volume:98 Page:34-43
ISSN:0001-6349
Container-title:Acta Obstetricia et Gynecologica Scandinavica
language:en
Short-container-title:Acta Obstet Gynecol Scand

Author:

Sørensen Sarah M.¹^ORCID,Schnack Tine H.¹^ORCID,Høgdall Claus¹

Affiliation:

1. Department of Gynecology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/aogs.13453

Reference31 articles.

1. Danish Gynecologic Cancer Database. Nationwide Clinical Database for Ovarian Endometrial and Cervical Cancer. National Report 2015/2016.http://www.dgcg.dk/images/rsrapport_DGCD_2015‐16_endelig_anonymiseret.pdf. Accessed September 19 2018.

2. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis

3. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

4. Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA–IV: Analysis of the OVCAD Data

5. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paired comparison of the analytical performance between the Oncomine™ Comprehensive Assay v3 and whole-exome sequencing of ovarian cancer tissue;Molecular Biology Reports;2024-07-17

2. Impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer: A multicenter randomized clinical trial protocol (FRAGINOC);Journal of Geriatric Oncology;2024-04

3. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis;BMC Women's Health;2024-03-15

4. Association between the quantitative characteristics of dual-energy spectral CT and cytoreduction surgery outcome in patients with advanced epithelial ovarian cancers: A prospective observational study;Medicine;2024-03-08

5. Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer;International Journal of Molecular Sciences;2023-09-21